Advertisement
Advertisement

IMUX

IMUX logo

Immunic Inc

1.05
USD
-0.045
-4.13%
Dec 18, 15:59 UTC -5
Closed
...

Immunic Inc Profile

About

Immunic Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis and psoriasis. The company's product candidate consists of IMU-838, IMU-935 and IMU-856 which are in clinical stage. Immunic Inc., formerly known as Vital Therapies Inc., is based in San Diego, United States.

Info & Links

CEO

Daniel Vitt

Headquarters

1200 AVENUE, SUITE 200
NEW YORK, NY 10036, UNITED STATES

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.immunic-therapeutics.com

Auditor

Baker Tilly US, LLP

Share holders

53

Employees

77

Immunic Inc Statistics

Valuation Measures

Market Capitalization2

94.13M

Enterprise Value

35.06M

Enterprise Value/EBITDA(ttm)

-0.37

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.47

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-169.55%

Return on Invested Capital(ttm)

-202.71%

Return on Assets(ttm)

-118.96%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-95.68M

Net Income Available to Common(ttm)

-96.90M

Diluted EPS(ttm)

-1.23

Share Statistics

Beta (5Y Monthly)

1.89

52-Week Change

-11.44%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

90.08M

Dividend Yield

0.00%

Float4

87.38M

% Held by Insiders

3.00%

% Held by Institutions

51.82%

Balance Sheet

Total Cash(mrq)

59.07M

Total Cash Per Share(mrq)

0.66

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

2.71%

Quick Ratio(mrq)

2.71%

Book Value Per Share(mrq)

0.46

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.61

Free Cash Flow(ytd)

-62.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement